Wnt proteins constitute a family of secreted glycoproteins that regulate the Wnt/β-catenin signaling pathway, as well as the planar cell polarity and Ca 2+ signaling pathways. The Wnt/β-catenin signaling pathway controls cell proliferation and differentiation in diverse contexts, including embryonic development and adult homeostasis, and dysregulation is tightly associated with cancer, bone anomalies and other diseases [1] [2] [3] [4] . Signaling is initiated when Wnt proteins simultaneously interact with their receptor and co-receptor, Frizzled (Fzd) and LRP5/6. The formation of the Fzd-Wnt-LRP5/6 ternary complex then leads to phosphorylation of the intracellular domain of LRP5/6 and to transduction of the Wnt signal inside the cell 5, 6 .
a r t i c l e s
Wnt proteins constitute a family of secreted glycoproteins that regulate the Wnt/β-catenin signaling pathway, as well as the planar cell polarity and Ca 2+ signaling pathways. The Wnt/β-catenin signaling pathway controls cell proliferation and differentiation in diverse contexts, including embryonic development and adult homeostasis, and dysregulation is tightly associated with cancer, bone anomalies and other diseases [1] [2] [3] [4] . Signaling is initiated when Wnt proteins simultaneously interact with their receptor and co-receptor, Frizzled (Fzd) and LRP5/6. The formation of the Fzd-Wnt-LRP5/6 ternary complex then leads to phosphorylation of the intracellular domain of LRP5/6 and to transduction of the Wnt signal inside the cell 5, 6 .
LRP5 and LRP6 form a subfamily of the LDL receptor (LDLR) family, share 73% identity in their extracellular domains and are essential for Wnt/β-catenin signaling [7] [8] [9] [10] [11] [12] [13] . The LRP5/6 extracellular domains consist of three types of subdomains: the YWTD-type β-propeller domain, the EGF-like domain and the LDLR type A (LA) domain (Fig. 1a) . Based on the crystal structures of the LDL receptor that contains a single propeller, the YWTD-type β-propeller domain has six YWTD repeats, which form a six-bladed β-propeller structure [14] [15] [16] . The four propeller domains in LRP5/6 share a relatively low identity among them (~19% for human LRP6; Supplementary Fig. 1 ), indicating the functional differences among these YWTD propellers. Each YWTD propeller domain is followed by an ~40-residue EGFlike domain that may cover the bottom face of the YWTD propeller, similar to LDLR [14] [15] [16] . The small LA domains in LRP5/6 seem to be dispensable for binding extracellular ligands Wnt and DKK 17 . Although understanding the structures of LRP5/6 is clearly important for understanding the mechanisms of signal transduction and for identifying candidate new therapeutics, there have been no previous reports of the structure of the extracellular domain of LRP5/6.
There is considerable interest in understanding how LRP5/6 interacts with its regulatory proteins. DKKs, exemplified by DKK1, are secreted glycoproteins that specifically inhibit Wnt/β-catenin signaling by antagonizing LRP5/6 (refs. [10] [11] [12] [13] . Structurally, DKKs contain two characteristic cysteine-rich domains, of which the C-terminal domain is highly conserved and belongs to the Colipase family 18 . Analysis of individual DKK domains and chimeric DKKs shows that the DKK C-terminal domains interact with LRP6 and are necessary and sufficient for Wnt inhibition 19 . DKKs mainly interact with the third and fourth propellers of LRP5/6 but can also bind to the first and second propellers 17 . Two mechanisms have been proposed for DKK1 antagonism of LRP5/6. The first supports DKK1 inhibition of Wnt/β-catenin signaling mainly by binding LRP5/6 and disrupting the Wnt-induced Fzd-Wnt-LRP6 complex 10 , whereas the second mechanism supports a DKK1-and Kremen-dependent induction of LRP5/6 endocytosis and degradation in specific tissues 13, 20, 21 .
Modulation of the interactions between LRP5/6 and DKK would be an attractive therapeutic goal for treating multiple diseases, including osteoporosis, multiple myeloma, osteosarcoma and melanoma [22] [23] [24] . LRP5 mutations are associated with osteoporosis pseudoglioma syndrome (OPPG) and autosomal dominant high bone mass (HBM) [25] [26] [27] , and LRP6 mutations have been linked to early coronary disease and metabolic risk factors 28 . Additionally, reduction of DKK1 results in increased bone mass in mice and has become an important drug target a r t i c l e s for the treatment of osteoporosis 29, 30 . Finally, antibodies targeting DKK1 have been used to treat bone tissue loss in mouse models of multiple myeloma 31 and osteoarthritis.
A detailed analysis of how LRP5/6 interacts with both activators and inhibitors of Wnt/β-catenin signaling and elucidating whether these interactions induce conformational changes in LRP5/6 are crucial for understanding how LRP5/6 functions as a Wnt co-receptor as well as validating it as a therapeutic target. To understand why LRP5/6 is essential in transducing Wnt signaling and how DKK1 inhibits Wnt signaling through its interaction with LRP5/6, we have determined crystal structures of the extracellular domain of human LRP6 and compared this with the structure of its complex with human DKK1. Combined with EM and mutation-function analysis, our work advances our understanding of the three-dimensional structure of the extracellular domain of LRP5/6 and provides new insights into how DKK inhibits Wnt/β-catenin signaling by interacting with LRP5/6.
RESULTS

Crystal structure of the first two YWTD-EGF pairs of LRP6
For simplicity we refer to the LRP6 fragment containing the first 'YWTDtype β-propeller and EGF pair' as LRP6-E1, the second YWTD-type β-propeller and EGF pair as LRP6-E2, and so on (Fig. 1a) . We overexpressed human LRP6-E1E2 using a baculovirus secretion system and purified it to homogeneity. We then determined the crystal structure of LRP6-E1E2 by molecular replacement, using the LDLR YWTD β-propeller as the search model. We built the two EGF domains into the electron density manually and refined the structure at 2.8 Å resolution ( Table 1) . There are two LRP6-E1E2 copies in the asymmetric unit, with almost identical structures (with an r.m.s. deviation of 0.92 Å for 567 Cα atoms in LRP6-E1E2). In each copy, the two YWTD β-propellers reside with the propeller axis roughly in parallel. Each of the two EGF domains packs tightly against the bottom surface of the preceding YWTD β-propeller in a manner almost identical to that of the YWTD-EGF pair in LDLR (Fig. 1b,c) . In fact, all ten YWTD-EGF pairs (two copies for LRP6-E1 and LRP6-E2, and three copies for LRP6-E3 and LRP6-E4) in the three crystal structures reported here have the same YWTD-EGF interdomain orientation, strongly indicating that this structural arrangement may be preserved in all LDLR family members. It should be noted that there are side-by-side interactions for LRP6-E1 and LRP6-E2, and the EGF domain in LRP6-E1 interacts with a r t i c l e s both the YWTD propellers 1 and 2, which may be important for stabilizing the relative orientation of LRP6-E1 and LRP6-E2 (see below). Consistent with the N-glycosylation site prediction, we found electron densities for sugar moieties for three glycosylation sites in LRP6-E1E2. These glycosylation sites are all on the propeller side surface or EGF repeats and are not expected to have a role in binding of the LRP6 ligand for the top surface (Fig. 1b) . The top surfaces of the LRP6-E1 and LRP6-E2 β-propellers contain a hydrophobic patch, whereas the remainder of these top surfaces is largely negatively charged (Fig. 1d) . Residues on the LRP6-E1 and LRP6-E2 top surfaces are conserved among corresponding LRP5/6 propellers. Notably, several missense mutations associated with high bone density syndrome, including D111Y, G171V, G171R, A214V, A214T and A242T, are mapped to the top surface of the LRP6-E1 β-propeller (Fig. 1b) . As these mutants were shown to be defective in inhibition of Wnt signaling by DKK1 (ref. 32) , the top surface of the LRP6-E1 β-propeller is expected to be involved in DKK1 interaction.
Crystal structure of the third and fourth YWTD-EGF pairs of LRP6 Next, we overexpressed the distinct domain LRP6-E3E4 using a baculovirus secretion system and purified it to homogeneity. We determined the crystal structure of LRP6-E3E4 by molecular replacement and refined it to 2.8 Å resolution ( Table 1) . There is one copy of LRP6-E3E4 in the crystal asymmetric unit. We found electron densities for sugar moieties for four glycosylation sites in LRP6-E3E4, with none of them on the propeller top surfaces. The overall structure of LRP6-E3E4 is similar to that of LRP6-E1E2 (Fig. 2a) . The top surface of LRP6-E3 is highly negatively charged. LRP6-E3, but not LRP6-E4, contains the hydrophobic patch on the top surface of propellers that is also observed in LRP6-E1 and LRP6-E2 (Fig. 2b) . Structural comparison shows that the top surface of LRP6-E2 is markedly different from that of LRP6-E3 in our crystal structures. In contrast, LRP6-E1 has a top surface similar to that of LRP6-E3 (Fig. 2c) .
LRP6-E1E4 contains two rigid structural blocks linked by a hinge
Including the two LRP6-E3E4 copies in the crystal structure of the LRP6-E3E4-DKK1c complex, which will be discussed below, the three crystal structures presented here represent five dual propeller structures of LRP6-E1E2 or LRP6-E3E4 from distinct crystallization conditions and from completely different crystal packing environments. Notably, when superimposed, all five dual propeller structures a r t i c l e s have essentially identical main chain traces (Fig. 3a,b) . The relative orientations among all four domains (YWTD-EGF-YWTD-EGF) are fixed in all five LRP6-E1E2 and LRP6-E3E4 dual propeller structures (Fig. 3a,b) . This strongly suggests that the two propellers in both LRP6-E1E2 and LRP6-E3E4 are structurally coupled and can be considered as relatively rigid structural blocks. This rigidity between neighboring YWTD-EGF pairs may be largely attributable to the bridging EGF domains in LRP6-E1 and LRP6-E3 that interact with YWTD propellers on both sides. There are various direct inter-propeller interactions for YWTD propeller pairs LRP6-E1E2 and LRP6-E3E4, but the residues involved in these interactions are not conserved between the LRP6-E1E2 and E3E4 interfaces and may have auxiliary roles in stabilizing LRP6-E1E2 and LRP6-E3E4 structural blocks.
To determine whether the orientation between these two structural blocks is also fixed, we visualized LRP6-E1E4, which contains all four LRP6 propeller-EGF pairs, using EM of negatively stained LRP6-E1E4 samples. EM images indicated that LRP6-E1E4 can be visualized in many different shapes that are apparently not from a uniform conformation (Fig. 3c) . We propose that there is likely to be a hinge between LRP6-E2 and LRP6-E3. This idea is consistent with the previous observation that LRP6-E3 cannot be secreted when overexpressed in mammalian cells on its own or in combination with LRP6-E1E2, but its secretion is vastly enhanced when expressed together with LRP6-E4, indicating a lack of cofolding effect between LRP6-E2 and LRP6-E3 (ref. 33) . It is important that both copies of the second EGF domain (EGF2) are well ordered in the identical position relative to the second β-propeller in our LRP6-E1E2 crystal structure (Fig. 3a) . There are only two conserved linker residues (Pro630-Glu631) between the C terminus of the well-ordered EGF2 domain and the beginning of the globularly folded propeller 3, both of which are located on bottom surfaces of the LRP6-E1E2 and LRP6-E3E4 blocks. The hinge flexibility provided by such a short linker is limited. For example, the bottom surfaces of LRP6-E1E2 and LRP6-E3E4 may approach each other, but the top surfaces of propellers from the same LRP6 molecule, which may provide binding surfaces for various LRP6 partners, cannot face each other (Fig. 3d) .
Crystal structure of LRP6-E3E4 in complex with DKK1c
We next separately purified LRP6-E3E4 and the C-terminal domain of DKK1 (DKK1c). The two proteins were then mixed together with DKK1c in stoichiometric excess, and the complex containing both proteins, designated as the LRP6-E3E4-DKK1c complex, was purified using size-exclusion chromatography in preparation for crystallization. We determined the crystal structure by molecular replacement and refined it to 3.1 Å resolution (Fig. 4a,b) . There are two LRP6-E3E4 and one DKK1c molecules in the asymmetric unit. The LRP6-E3E4 structure is largely unchanged by the binding of DKK1c (Supplementary Fig. 2) . The structural topology of DKK1c, including the formation of five disulfide bonds, is the same as the unbound DKK2c NMR structure previously reported 34 . However, there are notable conformational differences in DKK1c compared with the unbound DKK2c NMR structure. Instead of having six β-strands in DKK2c, there are only four β-strands for DKK1c, with two each residing on two sides of a relatively flat structure (Fig. 4c) . There is one long loop between these two β-sheets, largely flexible in the DKK2c NMR structure, which is crucial for the binding of both LRP6-E3 copies. Both of these two LRP6-E3 propellers use their top surface to recognize the two sides of DKK1c in our crystal lattice.
Notably, one of these two DKK1c surfaces involved in LRP6 binding is the proposed binding site for Kremen (see below), a protein that has a role in the endocytosis and turnover of LRP5/ 6 (refs. 20,35) . As the physiological relevance of this interface (interface B) remains to be tested, here we emphasize only the other interface (interface A, Figs. 4 and 5a,b), which is supported by our functional assay (see below) and consistent with previous biochemical data 35 .
LRP6-E3E4-DKK1c interfaces
In both interfaces (interfaces A and B), the long loop of DKK1c (residues 222-231) forms the major binding site. Both LRP6-E3 YWTD propellers in the asymmetric unit dock on opposite sides of this DKK1 loop using their top surfaces, which contain a hydrophobic patch formed by residues Phe836, Trp850, Trp767, Tyr875, Met877, Tyr706 and Ile681. This hydrophobic patch forms the core interactions in both interfaces. It should be noted that residues in this hydrophobic patch are conserved among LRP5/6 propellers 1, 2 and 3, but not propeller 4 (Supplementary Fig. 1 ). This provides an explanation for why LRP6-E4 does not interact with DKK1c in our structure.
Interface A buries a surface area of 1,946 Å 2 , which is typical for specific protein-protein interactions 36 . In interface A, the hydrophobic patch on the top surface of LRP6-E3 interacts with DKK1c Phe205 and Trp206 in the short loop between the first two β-strands in DKK1c, and with three other hydrophobic side chains in the DKK1c long loop (Leu231, Ile233 and Phe234) (Fig. 5a,b) . This hydrophobic interaction is buttressed by several salt bridges and hydrogen bonds between LRP6-E3 and DKK1c: LRP6 Asp811 with DKK1 Arg236, LRP6 Glu708 with DKK1 His204, LRP6 Arg792 with DKK1 Glu232, and LRP6 His834 with DKK1 Ser228. In addition, the side chains of DKK1 Arg224 and Arg225 are at the tip of the loop and can interact with LRP6-E3 top surfaces on both sides. Arg236 and His204 have been implicated in LRP6-DKK1 interactions in a previous study 35 .
In interface B, most interactions are made by a segment in the DKK1c long loop on the top surface of the LRP6-E3 propeller (Fig. 5c) . This interface buries a surface area of 1,877 Å 2 . Here the LRP6-E3 top surface (Fig. 5c) . The Lys226 side chain points straight into the hole formed by the LRP6-E3 propeller and interacts with LRP6 Asp878. This interaction is enhanced by four hydrogen bonds in this region: LRP6 Asp811 with DKK1 His229, LRP6 Ser749 with DKK1 Lys222, LRP6 Arg792 with DKK1 Thr221, and LRP6 Arg751 with DKK1 His223. In addition to the interactions in this long loop region, there are several other interactions, including a salt bridge between LRP6 Asp830 and DKK1 Arg191 that is located near the other end of the interface B. It should be noted that DKK1 residues Arg191, Ser192 and Lys226 were implicated in Kremen binding 35 .
Mutagenesis analysis of DKK1 residues in the LRP6-DKK1 interface
To validate the physiological relevance of our crystal structures and to evaluate the importance of the residues involved in the interaction between LRP6 and DKK1, we mutated DKK1 at positions within the observed LRP6-DKK1 interfaces. Specifically, we converted different amino acids into the neutral amino acid alanine, and then we used a robust luciferase reporter assay for Wnt/β-catenin signaling to monitor whether the mutations altered the ability of DKK1 to repress Wnt/β-catenin signaling in cells cultured in vitro. Mutation of interface A residues had strong effects (Fig. 6a) . Mutation of DKK1c hydrophobic residues (Ile233, Phe234, Phe205 and Trp206), as well as Arg236, completely abolished DKK1-mediated inhibition of Wnt/β-catenin signaling, whereas DKK1 mutants H204A and E232A showed reduced activity (Fig. 6a) . This is consistent with previous results showing that mutations in mouse DKK1 corresponding to human DKK1 H204E and R236E abolish repression of Wnt/β-catenin signaling by DKK1 (ref. 35 ). In comparison, mutations in interface B had much milder effects (Fig. 6b) . The only mutation involving interface B that completely abolished DKK1 activity was the R224A R225A double mutation. In this case, Arg224 and Arg225 should be counted for both interfaces A and B, as they can interact with both LRP6 copies in the crystal structure. Thus, missense mutations on both DKK1c surfaces can suppress the ability of DKK1 to antagonize Wnt/β-catenin signaling. Together, these results are consistent with the binding interfaces revealed by our crystal structure and support their physiological relevance.
Biochemical characterization of the LRP6-DKK1c interaction
To further characterize the interaction between DKK1c and LRP6, we determined the affinity of DKK1c for LRP6-E1E2 and LRP6-E3E4 using an Alpha Technology binding assay (Supplementary Fig. 3 ). Purified DKK1c interacted with both LRP6-E1E2 and LRP6-E3E4 fragments with K d values of 70 nM and 50 nM, respectively, comparable with previously reported corresponding K d values for the full-length DKK1 (64 nM and 21 nM, respectively) 17 . This result and our mutagenesis data (Fig. 6) are consistent with the conclusion that DKK1c is necessary and sufficient for the LRP6-DKK1 interaction and Wnt inhibition 19 . a b Figure 6 DKK1 residues in the DKK1-LRP5/6 interface are important for its inhibitory effects on Wnt/β-catenin signaling. Conditioned media was generated for each of the indicated DKK1 constructs carrying mutations on interface A (a) or interface B (b), and each was tested for its ability to inhibit Wnt3a-mediated β-catenin signaling in RKO cells, as measured by a β-catenin-activated reporter (BAR). Assays were done in triplicate and error bars represent s.d. Reporter data were normalized to expression of the corresponding DKK1 wild-type or mutant protein as determined by densitometric analysis of a western blot (Supplementary Fig. 6 ).
a r t i c l e s
We next explored the stoichiometry of DKK1c and LRP6 in solution by size-exclusion chromatography and dynamic light scattering analysis. The LRP6-E3E4-DKK1c complex existed mostly in a 1:1 molar ratio in solution ( Supplementary Fig. 4) , which suggests that the LRP6-E3E4-DKK1c interaction through interface B is not stably formed in solution. In contrast, the presence of DKK1c can substantially induce LRP6-E1E4 oligomerization ( Supplementary Fig. 4) , which is consistent with the possibility of DKK1c containing two LRP6-binding surfaces. It remains to be tested whether the LRP6-interface B we observed is physiologically relevant. This is pertinent because the presence of Wnt3a quickly induces plasma membrane-associated LRP6 aggregates 37 , in which the local LRP6 concentration could be high enough for the LRP6-DKK1 interaction through interface B.
DISCUSSION
The Wnt/β-catenin signaling pathway is involved in many biological processes and is regulated by both extracellular and intracellular signals. It is generally accepted that the initiation of signal transduction at the plasma membrane involves formation of a ternary complex between the secreted Wnt ligand and the integral membrane proteins Fzd and LRP5/6. Members of the Fzd family act as receptors for Wnts, whereas LRP5/6 is an essential Wnt co-receptor that serves as a crucial point of signal integration by interacting with multiple partners, including DKK, sclerostin (SOST) and R-spondin, in addition to Wnts 11, 29, 38, 39 . Whereas Wnt and R-spondin activate the Wnt/β-catenin pathway, DKK and SOST are known to be potent inhibitors of this pathway. The LRP5/6 extracellular domain (ECD) contains four YWTD-type β-propeller and EGF-like domain pairs, followed by three LA domains (Fig. 1a) . The LA domains are expected to be structurally uncoupled, according to structural studies of LA domains in LDLR 16, 40 , and are dispensable for Wnt/β-catenin signaling 17 . It is important to know whether these propeller-EGF domains function independently, similar to 'strings and beads' , or are structurally coupled, thereby allowing for allosteric regulation.
LRP5/6-ECD contains two rigid 'propeller-EGF' structural blocks
Notably, in the three crystal structures presented here, all five LRP6-E1E2 and LRP6-E3E4 pairs have almost identical main chain structures, despite being in a distinct chemical environment in their respective crystal lattices. This argues strongly that the LRP6-E1E2 and LRP6-E3E4 pairs are structurally coupled and form relatively rigid structural blocks, in which the top surfaces of the coupled propellers are roughly next to each other. Our EM analysis indicates that the relative orientation of the LRP6-E1E2 and LRP6-E3E4 blocks is not fixed. However, the short linker connecting these two structural blocks is located on the bottom surfaces of both blocks, and one of the two residues in the linker is proline, which makes the main chain less flexible than would most other residues. This not only allows the bottom surfaces of the two blocks to approach each other, but also prevents the top surfaces from approaching each other (Fig. 3d) . The protein SOST has been shown to interact with the top surface of the LRP6-E1 propeller and to inhibit Wnt signaling by competing with Wnt for binding to LRP5/6-E1 (refs. 17,34,41-45) . At least some of the Wnt proteins are expected to bind to the propeller top surfaces as well, as DKK1 was shown to compete with Wnt3a and Wnt9b for binding to LRP6 (ref. 17) . Given that most Wnt proteins and the extracellular domain of Fzd are much smaller than the LRP6-E1E2 and LRP6-E3E4 blocks (~90 Å in the long dimension) of LRP5/6 in this restrained interblock orientation, one can expect that the top surface(s) of the LRP5/6 extracellular domain needs to be close to the membrane when forming the Fzd-Wnt-LRP ternary complex. It is plausible that Wnt signaling activities require the appropriate spatial arrangement of Fzd, Wnt and LRP5/6, and the dynamic properties of the LRP5/6 structure could be a key factor.
Would such structural coupling affect Wnt signaling? One potential example is a LRP6-R611C missense mutation found in patients with coronary artery disease. LRP6 Arg611 is located near the tip of the extruding EGF2 domain, and it may have a role in stabilizing the position of this EGF domain by forming a salt bridge with Glu477 in the LRP6-E2 propeller domain (Supplementary Fig. 5a ). R611C may relax the relative orientation between the YWTD and EGF domains in LRP6-E2, which may in turn affect the orientation or structural dynamics between the two LRP6 structural blocks. Alternatively, the R611C mutation may perturb disulfide bond formation, and therefore the folding of the EGF2 domain, by providing an additional cysteine residue.
Structural basis of the LRP5/6-DKK1 interaction
Our LRP6-E3E4-DKK1c crystal structure reveals two LRP6-DKK1c interfaces. Interface A uses a hydrophobic interaction as the core for binding, and its existence and physiological relevance is supported by current and previous mutagenesis data. Given the key interactions identified by our crystal structure, it is apparent that LRP6-E4 cannot bind to DKK1, as it lacks this hydrophobic patch on the top surface ( Fig. 2  and Supplementary Fig. 1 ). Does DKK1c interact with LRP6-E1, or LRP6-E2 or with both? As LRP6-E1, but not LRP6-E2, has a top surface similar to that of LRP6-E3 (Fig. 2c) , LRP6-E3 and LRP6-E1 may form two discrete DKK1c-binding sites with similar binding modes, whereas LRP6-E2 may not be compatible with DKK1c binding. This structural analysis is consistent with the LRP5 mutations found in patients with HBM. These mutations are in the top surface of LRP5-E1 propeller and have been shown to disrupt the LRP5-DKK1 interaction 32 (Fig. 1b) .
Our structures provide explanations for the activities of LRP5 mutations associated with HBM. For example, the LRP5 G171V mutant is associated with HBM and shows reduced binding to DKK1 (ref. 46 ). In our crystal structure, the main chain amine of Val219 of DKK1c forms a hydrogen bond with the main chain carbonyl of LRP6-E3 residue Gly769 (Supplementary Fig. 5b ). The LRP6 G768V mutation (corresponding to G171V in LRP5-E1) would change the conformation of a β-turn formed by Gly768 and Gly769 and may disrupt this hydrogen bond. Assuming LRP5-E1 and LRP6-E3 interact with DKK1 in the same way, G171V may weaken the LRP5-DKK1 interaction for the same reason.
It is notable that we observed a second LRP6-DKK1 interface (interface B), which overlaps with a previously proposed Kremen-binding surface 35 . Our mutagenesis data on interface B (Fig. 6b) could be partially explained by the lack of Kremen-binding activities, but the potential involvement of interface B in the LRP5/6-DKK1 interaction in the cell cannot be excluded. If LRP6 can interact with both surfaces of DKK1c, LRP6 can also compete with Kremen binding, and thus the resulting output would depend on the local concentrations of LRP5/6, DKK1 and Kremen. Answering the question of how DKKs interact with LRP5/6 and regulate Wnt signaling in vivo will require further investigations.
Implications for Wnt signaling and drug discovery
Antibodies or inhibitors that disrupt the LRP5/6-DKK1 interaction are potentially useful for treatment of osteoporosis and other diseases 29, 30 . The top surfaces of the LRP6-E1 and LRP6-E3 propellers contain hydrophobic pockets that are amenable for developing small-molecule inhibitors (Fig. 5b) , especially as most of these residues are from the loop regions of propeller domains and thus have a certain degree of conformational flexibility to generate deeper pockets for small-molecule drugs. In addition, our structural model of the LRP6 extracellular domain indicates that the LRP6 ligand-binding domains may be regulated allosterically. a r t i c l e s Therefore, we predict that it is possible to develop allosteric Wnt pathway regulators by targeting the LRP5/6 extracellular domain.
DKK1 is known to compete with Wnt for LRP5/6 binding 17 . In addition, it has been shown that Wnt1 and Wnt9b bind to LRP6-E1E2, whereas Wnt3a binds to LRP6-E3E4, and that LRP6-E1 and LRP6-E3 may be the major ligand-binding sites 17, 47, 48 . Because of the structural rigidity, to allow for the competition by small DKK proteins, Wnt proteins may bind to the top surface of LRP6-E1 and LRP6-E3 as well. As the hydrophobic patches on the top surfaces of LRP6-E1 and LRP6-E3 are the LRP6-DKK1 interaction cores, we predict that these two hydrophobic patches may form part of the Wnt-binding sites. We expect these and other predictions based on structural analyses to advance the discovery of drugs targeting the Wnt/β-catenin pathway.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
ONLINE METHODS
Protein expression and purification. Extracellular domains of human LRP6, including LRP6-E1E2 (residues 20-629), LRP6-E3E4 (residues 630-1244) and LRP6-E1E4 (residues 20-1244), were overexpressed using a pAcGP67A vector in a BaculoGold secreted baculovirus and Hi5 insect cell system. Human DKK1 C-terminal cysteine-rich domain DKK1c (residues 183-266) was cloned and expressed as a thioredoxin-His 6 fusion protein in Escherichia coli strain BL-21. LRP6 proteins were purified using Ni-NTA resin, HiTrap Q anion exchange and Superdex-200 size-exclusion columns (GE Life Sciences). Human DKK1c proteins were purified using Ni-NTA resin. After removal of the thioredoxin tag, DKK1c was further purified with HiTrap S cation exchange and a Superdex-75 size-exclusion column. A five-fold excess of DKK1c was mixed with corresponding LRP6 proteins and further purified by a Superdex-200 size-exclusion column. The proteins (LRP6-E1E2 or LRP6-E3E4) and protein complex (LRP6-E3E4-DKK1c) were concentrated to 5 mg ml −1 , 10 mg ml −1 and 5 mg ml −1 , respectively, for crystallization. Structure determination and refinement. All three structures were determined by molecular replacement with the program PHASER 51 , using the crystal structure of the LDL receptor YWTD domain 14 (PDB 1IJQ) as the initial search model. Solutions for individual YWTD domains were found sequentially. After several cycles of refinement using REFMAC5 (ref. 52), EGF-like domains (and DKK1c in the case of the LRP6-E3E4-DKK1c complex structure) were built manually using Coot 53 . Crystallographic refinement was carried out with REFMAC5 with TLS parameters. For the LRP6-E1E2 structure, the last residue that is well ordered in an identical position in both LRP6-E1E2 copies is Val629, the last residue in the EGF2 domain. LRP6 residue Pro630 is visible in only one copy. In the LRP6-E3E4 structures, the first residue that is well ordered in the same position in all three LRP6-E3E4 copies is Ala632, which is immediately before the first β-strand of YWTD propeller 3. Ramachandran statistics for the refined coordinates (residues in favored region (%), number of outliers): LRP6-E1E2 (98.2, 0), LRP6-E3E4 (98, 2) and LRP6-E3E4-DKK1c (98. 5, 3) . The final refinement statistics are summarized in Table 1 .
Electron microscopy imaging. Transmission EM grids coated with continuous carbon films were glow discharged in air for 20 s. We loaded 6 µl of LRP-E1E4 onto the carbon side for 2 min and blotted from the side. Then, 10 µl of 2% (w/v) uranyl acetate was loaded onto the carbon side for 2 min and blotted from the side. The sample was dried in air. Images were obtained using a Tecnai F20 electron microscope (FEI) at 200 keV with a 30-µm objective aperture. Images were taken at 97,000 magnification and about -1 µm defocus and recorded on a Gatan 2K × 2K CCD camera with an effective pixel size of 0.11 nm.
Cell culture. HEK293T (CRL-11268) and RKO (CRL-2577) cells were obtained from ATCC and were cultured in DMEM supplemented with 10% (v/v) FBS (Invitrogen) and 1% Pen-Strep (Invitrogen).
Conditioned media. Wnt3a-conditioned medium was harvested from Wnt3a expressing L-cells as described 54 . DKK1-conditioned medium was harvested from HEK293T cells transiently transfect with DKK1 expression constructs. Briefly, HEK293T cells were seeded in six-well plates and transfected with 1.5 mg of the appropriate Flag-tagged DKK1 expression construct using Lipofectamine 2000 as directed by the manufacturer (Invitrogen). DKK1-conditioned medium was harvested 24 h after transfection.
Western blotting. Conditioned media were combined with LDS sample buffer and a final concentration of 50 mM DTT. Samples were run on NuPAGE 4-12% Bis-Tris gels and transferred to nitrocellulose. Blots were stained with Ponceau S and imaged for protein loading comparison (Supplementary Fig. 6 ). Blots were probed with anti-Flag antibody (Sigma), followed by horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson) and developed with an ECL detection kit (Pierce).
β-catenin-activated reporter assay. Detailed information on the BAR has been described 55 . RKO cells stably expressing the BAR reporter (RKO-BAR) were generated as described 54 . RKO-BAR luciferase cells were also infected with a lentivirus carrying Renilla luciferase driven by a constitutive EF1alpha promoter, which was used for assay normalization. RKO-BAR cells were seeded in 96-well plates at 30,000 cells per well. After 24 h, the medium was replaced with a single dose of Wnt3a-conditioned medium combined with increasing amounts of control, DKK1-or mutant DKK1-conditioned medium and incubated for an additional 24 h. The medium was then aspirated and the cells were lysed with 25 µl of 1× passive lysis buffer (Promega). We then assayed 10 µl of lysate for both firefly (BAR reporter) and Renilla (normalization) luciferase activity using the dual luciferase assay (Promega) and an Envision multilabel plate reader (PerkinElmer).
Alpha binding assay. The measurement was based on the 'Determining K d with an Alpha assay' protocol from PerkinElmer. Streptavidin donor beads and glutathione acceptor beads (Perkin Elmer) were used in this assay. Biotinylation of LRP6-E1E2 and LRP6-E3E4 proteins was done with the ChromaLink Biotin Protein Labeling Kit (Solulink). Gradients of untagged DKK1c (0-10 µM) were used to titrate the interaction between biotinylated LRP6 proteins and GST-DKK1c. The concentrations of biotinylated LRP6 proteins and GST-DKK1c used were 4 nM and 10 nM, respectively. The concentration for both donor and acceptor beads was 20 µg ml −1 . The assay was done in a solution containing 1× PBS buffer (pH 7.5) with 0.5% (w/v) BSA. Data were analyzed with a one-site competition model using nonlinear regression with the software GRAPHPAD PRISM (GraphPad).
